Biomedicines (May 2024)

Vascular Endothelial Growth Factor (VEGF) and Its Role in the Cardiovascular System

  • Kamila Florek,
  • Dominik Mendyka,
  • Krzysztof Gomułka

DOI
https://doi.org/10.3390/biomedicines12051055
Journal volume & issue
Vol. 12, no. 5
p. 1055

Abstract

Read online

Cardiovascular diseases remain the leading cause of death worldwide, with ischemic heart disease (IHD) as the most common. Ischemia-induced angiogenesis is a process in which vascular endothelial growth factor (VEGF) plays a crucial role. To conduct research in the field of VEGF’s association in cardiovascular diseases, it is vital to understand its role in the physiological and pathological processes in the heart. VEGF-based therapies have demonstrated a promising role in preclinical studies. However, their potential in human therapies is currently under discussion. Furthermore, VEGF is considered a potential biomarker for collateral circulation assessment and heart failure (HF) mortality. Additionally, as VEGF is involved in angiogenesis, there is a need to elucidate the impact of VEGF-targeted therapies in terms of cardiovascular side effects.

Keywords